Peer Review reports
From: Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
| Original Submission | ||
|---|---|---|
| 16 Nov 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 2 Dec 2021 | Reviewed | Reviewer Report |
| 6 Dec 2021 | Reviewed | Reviewer Report |
| 13 Dec 2021 | Reviewed | Reviewer Report |
| 4 Jan 2022 | Author responded | Author comments - Stefanie D. Krens |
| Resubmission - Version 3 | ||
| 4 Jan 2022 | Submitted | Manuscript version 3 |
| 2 Feb 2022 | Author responded | Author comments - Stefanie D. Krens |
| Resubmission - Version 4 | ||
| 2 Feb 2022 | Submitted | Manuscript version 4 |
| 14 Feb 2022 | Reviewed | Reviewer Report |
| 15 Feb 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 17 Feb 2022 | Editorially accepted | |
| 2 Mar 2022 | Article published | 10.1186/s12885-022-09338-1 |
You can find further information about peer review here.